Inspire has announced that it will present new research at Digestive Disease Week (DDW) 2024, unveiling insights from a mixed-method study on Short Bowel Syndrome (SBS) patient experience.
Inspire has announced that it will present new research at Digestive Disease Week (DDW) 2024, unveiling insights from a mixed-method study on Short Bowel Syndrome (SBS) patient experience.
Inspire has announced that it will present new research at Digestive Disease Week (DDW) 2024, unveiling insights from a mixed-method study on Short Bowel Syndrome (SBS) patient experience.
Inspire is pleased to announce the hiring of Alya Sherman to the position of Vice President of Business Development to support the company’s growing offerings in healthcare advertising.
Inspire is pleased to announce the hiring of Alya Sherman to the position of Vice President of Business Development to support the company’s growing offerings in healthcare advertising.
A presentation at ICPE 2023: The Global Home for the Science of Real-World Evidence titled “Understanding Short Bowel Syndrome via Real-World Data” helped illuminate the challenges faced by short bowel syndrome (SBS) patients. The study, led by Inspire, the leading patient engagement and real-world evidence platform, aims to bridge the knowledge gap surrounding SBS.
A presentation at ICPE 2023: The Global Home for the Science of Real-World Evidence titled “Understanding Short Bowel Syndrome via Real-World Data” helped illuminate the challenges faced by short bowel syndrome (SBS) patients. The study, led by Inspire, the leading patient engagement and real-world evidence platform, aims to bridge the knowledge gap surrounding SBS.
A presentation at ICPE 2023: The Global Home for the Science of Real-World Evidence titled “Understanding Short Bowel Syndrome via Real-World Data” helped illuminate the challenges faced by short bowel syndrome (SBS) patients. The study, led by Inspire, the leading patient engagement and real-world evidence platform, aims to bridge the knowledge gap surrounding SBS.
A presentation at ICPE 2023: The Global Home for the Science of Real-World Evidence titled “Understanding Short Bowel Syndrome via Real-World Data” helped illuminate the challenges faced by short bowel syndrome (SBS) patients. The study, led by Inspire, the leading patient engagement and real-world evidence platform, aims to bridge the knowledge gap surrounding SBS.
A presentation at ICPE 2023: The Global Home for the Science of Real-World Evidence titled “Understanding Short Bowel Syndrome via Real-World Data” helped illuminate the challenges faced by short bowel syndrome (SBS) patients. The study, led by Inspire, the leading patient engagement and real-world evidence platform, aims to bridge the knowledge gap surrounding SBS.
